UCLA Researchers Receive NIH Grant to Launch Trial for Immunotherapy-related Diabetes
September 16, 2026
September 16, 2026
LOS ANGELES, California, Sept. 16 -- The UCLA Health issued the following news release:
* * *
UCLA researchers receive NIH grant to launch trial for immunotherapy-related diabetes
The phase 1/2 trial will evaluate whether JAK inhibitors can protect insulin-producing cells in patients who develop diabetes after cancer immunotherapy
-
UCLA researchers have received a grant worth up to $7 million over five years from the National Inst . . .
* * *
UCLA researchers receive NIH grant to launch trial for immunotherapy-related diabetes
The phase 1/2 trial will evaluate whether JAK inhibitors can protect insulin-producing cells in patients who develop diabetes after cancer immunotherapy
-
UCLA researchers have received a grant worth up to $7 million over five years from the National Inst . . .